Literature DB >> 145759

Induction of the deficient acid DNAse activity in mouse interfollicular epidermis by croton oil as a possible tumor promoting mechanism.

H S Taper.   

Abstract

Histochemical activity of acid DNAse, intensity of nucleic acid staining and histological alterations in mouse interfollicular epidermis (I.F.E.) were investigated after a single dose or after chronic topical administration of two hyperplastic agents, of which one (croton oil) was a potent tumor promotor, and the other one (podophyllin) did not promote skin carcinogenesis. Podophyllin induced intense uniform I.F.E. hyperplasia without any proliferation of poorly differentiated basal cells, without increased nucleic acid staining and without any appreciably decreased acid DNAse activity. On the other hand, croton oil (as well as TPA) produced almost immediate, distinct hyperplasia of poorly differentiated basal cells with increased intensity in the staining of both nucleic acids and nearly complete deficiency in acid DNAse activity. Similar histochemical and histological patterns were observed at the sites of wounding hyperplasia in untreated control mice. Such wounding hyperplasia was thought also to be a tumor promoting factor. It was suggested that the decrease in acid DNAse activity which occurred almost immediately after administration of potent tumor promoters and which could not be induced by a hyperplastic agent without tumor promoting action may have a particular importance in the mechanisms of tumor promotion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 145759     DOI: 10.1007/bf00285326

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  38 in total

1.  The distribution of deoxyribonuclease in normal, cirrhotic and neoplastic rat livers.

Authors:  R DAOUST; A CANTERO
Journal:  J Histochem Cytochem       Date:  1959-03       Impact factor: 2.479

2.  Mechanism of experimental tumorigenesis. I. Epidermal hyperplasia in mouse caused by locally applied tumor initiator and dipoletype tumor promotor.

Authors:  K SETALA; L MERENMIES; L STJERNVALL; Y AHO; P KAJANNE
Journal:  J Natl Cancer Inst       Date:  1959-11       Impact factor: 13.506

3.  On the biochemical mechanism of tumorigenesis in mouse skin. II. Early effects on the biosynthesis of nucleic acids induced by initiating doses of DMBA and by promoting doses of phorbol-12.13-diester TPA.

Authors:  D Paul; E Hecker
Journal:  Z Krebsforsch       Date:  1969

4.  Studies on the role of stimulated epidermal DNA synthesis in the initiation of skin tumors in mice by N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  G T Bowden; R K Boutwell
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

5.  Dose-response studies with a pure tumor-promoting agent, phorbol myristate acetate.

Authors:  B L Van Duuren; A Sivak; A Segal; I Seidman; C Katz
Journal:  Cancer Res       Date:  1973-09       Impact factor: 12.701

6.  The early stimulation of phospholipid metabolism by 12-0-tetradecanoyl-phorbol-13-acetate and its specificity for tumor promotion.

Authors:  L R Rohrschneider; R K Boutwell
Journal:  Cancer Res       Date:  1973-08       Impact factor: 12.701

7.  A histochemical study of alkaline and acid nuclease activity in the human brain compared to the incidence of malignant tumours.

Authors:  H S Taper; J M Brucher; G Doyen
Journal:  J Neurol Sci       Date:  1971-04       Impact factor: 3.181

8.  Nonspecific inhibition of DNA repair by promoting and nonpromoting phorbol esters.

Authors:  R Langenbach; C Kuszynski
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

9.  CONDITIONAL NEOPLASMS AND SUBTHRESHOLD NEOPLASTIC STATES : A STUDY OF THE TAR TUMORS OF RABBITS.

Authors:  P Rous; J G Kidd
Journal:  J Exp Med       Date:  1941-02-28       Impact factor: 14.307

10.  Studies on co-carcinogenesis. SH-reactors and other substances tested for co-carcinogenic action in mouse skin.

Authors:  R H GWYNN; M H SALAMAN
Journal:  Br J Cancer       Date:  1953-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.